ALZHEIMER'S DISEASE: A COMPREHENSIVE REVIEW
DOI:
https://doi.org/10.51891/rease.v10i7.14886Keywords:
Alzheimer's disease. Neurodegeneration. β-amyloid peptide. Tau protein.Abstract
Alzheimer's disease (AD) is a disorder that causes degeneration of brain cells and is the main cause of dementia, which is characterized by a decline in thinking and independence in daily personal activities. AD is a neurodegenerative disease and its pathogenesis has been attributed to extracellular aggregates of amyloid β (Aβ) plaques and intracellular neurofibrillary tangles made of hyperphosphorylated τ protein in cortical and limbic areas of the human brain. AD is considered a multifactorial disease and has several risk factors such as increasing age, genetic factors, head injuries, vascular diseases, infections and environmental factors play a role in the disease. Currently, there are only two classes of medications approved to treat AD, cholinesterase enzyme inhibitors and N -methyl d -aspartate (NMDA) antagonists, which are only effective in treating the symptoms of AD but do not cure or prevent the disease.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Atribuição CC BY